Back to stocks
NEUP
Neuphoria Therapeutics Inc.• Healthcare
Institutional holders
19
As of Q3 2026
Total 13F value
$6.3M
Sum of disclosed positions
New positions
4
This quarter
Sold positions
8
This quarter
Top holders
Institutions with disclosed positions in this stock
| Fund | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
Lynx1 Capital Management Lp | $3.1M | 875.3K | 0.48% | Unchanged |
Advisorshares Investments Llc | $1.1M | 312.9K | 0.14% | +23.7% |
Vanguard Capital Management Llc | $618K | 173.5K | 0.00% | Unchanged |
Shay Capital Llc | $463K | 130.0K | 0.03% | -16.6% |
Geode Capital Management, Llc | $180K | 50.6K | 0.00% | +2.3% |
Ikarian Capital, Llc | $169K | 47.4K | 0.02% | Unchanged |
Citadel Advisors | $157K | 44.0K | 0.00% | -39.3% |
Vanguard Fiduciary Trust Co | $120K | 33.8K | 0.00% | Unchanged |
Adar1 Capital Management, Llc | $107K | 30.0K | 0.00% | Unchanged |
Jane Street Group, Llc | $65K | 18.2K | 0.00% | +21.9% |
Susquehanna International Group, Llp | $52K | 14.7K | 0.00% | New Position |
Boothbay Fund Management, Llc | $50K | 14.0K | 0.00% | Unchanged |
Gts Securities Llc | $41K | 11.5K | 0.00% | New Position |
Merck & Co., Inc. | $36K | 10.0K | 0.00% | Unchanged |
Ubs Group Ag | $797 | 224 | 0.00% | -89.4% |
Morgan Stanley | $207 | 58 | 0.00% | Unchanged |
Allworth Financial Lp | $146 | 41 | 0.00% | — |
Fmr Llc | $57 | 16 | 0.00% | New Position |
Barclays Plc | $11 | 3 | 0.00% | New Position |